Dr. Leen Kawas is a scientist, entrepreneur, and healthcare executive. She has made significant contributions to the field of biotechnology and healthcare through her research, leadership, and innovation.

Dr. Kawas’ Bioscience Career

Dr. Kawas obtained her Doctorate in Molecular Pharmacology from Washington State University in 2011. Her research focused on developing new treatments for Alzheimer’s disease following her grandmother’s health deterioration from the disease. She co-founded M3 Biotechnology(Athira’s) and became the vice president. She served as the company’s CEO from 2012 to 2021 and led the company through several successful funding rounds, raising approximately $400 million.

Dr. Kawas’ Departure from M3 Biotechnology

In late 2021, Dr. Kawas was given a temporary leave and stepped down as the CEO of Athira. She departed amid the company’s board of directors’ investigation into her Washington State University doctoral work. Later, her Ph.D. adviser Joe Harding upheld her foundational science after his researchers repeated her experiment. Dr. Kawas admitted the wrongdoing in 2015 and said in a statement that there was room to make mistakes as a student.

Dr. Leen Kawas’ Commitment to the New Life Science Venture

Dr. Leen Kawas co-founded Propel Bio Partners LLC with Richard Kayne, a preceding Athira investor. She currently serves as the Managing General Partner of the international venture capital firm, which focuses on life science investments. Dr. Kawas says her management of the venture has made her recognized for her achievements and positive contributions to the field of bioscience.

Overall, Dr. Leen Kawas is a talented and accomplished bioscientist who has made significant contributions to the field of biotechnology and healthcare. Her passion for innovation and leadership has propelled her to success in both academia and industry.